Health care utilization in patients with migraine: Demographics and patterns of care in the ambulatory setting

Health care utilization in patients with migraine: Demographics and patterns of care in the ambulatory setting
复制标题

DOI:
10.1046/j.1526-4610.2003.03067.x
复制
发表时间:
2003-04-01
期刊:
影响因子:
5
通讯作者:
O'Donovan, CA
O'Donovan, CA
中科院分区:
医学3区
文献类型:
--
作者:
Gibbs, TS;Fleischer, AB;O'Donovan, CA

文献摘要

被引文献

相似文献

背景。-偏头痛影响所有种族和性别的人。偏头痛患者遭受经济损失和生活质量受损。偏头痛治疗的最新进展尚未提供给所有患有这种疾病的人。为了评估门诊医疗保健提供模式偏头痛患者在美国。从1990年到1998年的全国门诊医疗调查数据被用来评估诊断为偏头痛的患者的人口统计学,他们看到的医生类型以及用于治疗偏头痛的药物。女性占偏头痛就诊人数的79%,白人占91%。在研究期间,偏头痛的就诊人数急剧增加,从1990年的每1000人9.4次就诊增加到1998年的每1000人18次就诊。初级保健医生看到了大多数患者(72.2%)。布他比妥/阿司匹林/咖啡因是治疗偏头痛最常用的药物,其次是对乙酰氨基酚/dichloralphenazone/isometheptene mucate,普萘洛尔和舒马曲坦。也许部分是由于新的治疗选择,偏头痛治疗的就诊次数在研究期间翻了一番。即便如此,大多数偏头痛患者仍继续使用较旧且可能效果较差的药物治疗。
Background.-Migraine affects people of all races and both sexes. Migraineurs suffer both financial losses and impaired quality of life. Recent progress in the treatment of migraine has not been made readily available to all who suffer the condition.Objective.-To assess outpatient health care delivery patterns for migraine sufferers in the United States.Methods.-National Ambulatory Medical Care Survey data from 1990 to 1998 was used to assess the demographics of patients seen with a diagnosis of migraine, the types of physicians they saw, and the medications used to treat migraine.Results.-Women accounted for 79% of visits for migraines and whites for 91% of the visits. There was a dramatic increase in the number of migraine visits during the study period, from 9.4 visits per 1000 people in 1990 to 18 visits per 1000 in 1998. Primary care physicians saw the majority of patients (72.2%). Butalbital/aspirin/caffeine was the drug most commonly prescribed for migraine treatment, followed by acetaminophen/dichloralphenazone/isometheptene mucate, propranolol, and sumatriptan.Conclusion.-Perhaps in part due to newer treatment options, the number of visits for the treatment of migraine doubled over the study interval. Even so, most patients with migraine continue to be treated with older and presumably less effective medications.